vs
先锋自然资源公司（PR）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
先锋自然资源公司的季度营收约是百利高的1.1倍（$1.2B vs $1.1B），先锋自然资源公司净利率更高（29.0% vs -127.8%，领先156.8%），百利高同比增速更快（-2.5% vs -9.8%），过去两年百利高的营收复合增速更高（1.3% vs -3.0%）
先锋自然资源公司总部位于美国得克萨斯州欧文市，主要从事油气勘探业务，运营覆盖二叠纪盆地Spraberry产区的克莱恩页岩区块，是该区域最大的土地权益持有方，2024年5月被埃克森美孚收购。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
PR vs PRGO — 直观对比
营收规模更大
PR
是对方的1.1倍
$1.1B
营收增速更快
PRGO
高出7.3%
-9.8%
净利率更高
PR
高出156.8%
-127.8%
两年增速更快
PRGO
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.1B |
| 净利润 | $339.5M | $-1.4B |
| 毛利率 | — | 32.6% |
| 营业利润率 | 23.1% | -116.0% |
| 净利率 | 29.0% | -127.8% |
| 营收同比 | -9.8% | -2.5% |
| 净利润同比 | 56.7% | -3093.9% |
| 每股收益（稀释后） | $0.48 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRPRGO
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B | ||
| Q1 24 | $1.2B | $1.1B |
净利润PRPRGO
| Q4 25 | $339.5M | $-1.4B | ||
| Q3 25 | $59.2M | $7.5M | ||
| Q2 25 | $207.1M | $-8.4M | ||
| Q1 25 | $329.3M | $-6.4M | ||
| Q4 24 | $216.7M | $-44.4M | ||
| Q3 24 | $386.4M | $-21.0M | ||
| Q2 24 | $235.1M | $-108.4M | ||
| Q1 24 | $146.6M | $2.0M |
毛利率PRPRGO
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
营业利润率PRPRGO
| Q4 25 | 23.1% | -116.0% | ||
| Q3 25 | 29.6% | 7.0% | ||
| Q2 25 | 24.8% | 4.3% | ||
| Q1 25 | 36.6% | 4.5% | ||
| Q4 24 | 32.8% | 10.0% | ||
| Q3 24 | 32.5% | 7.4% | ||
| Q2 24 | 36.5% | -2.5% | ||
| Q1 24 | 37.7% | -5.1% |
净利率PRPRGO
| Q4 25 | 29.0% | -127.8% | ||
| Q3 25 | 4.5% | 0.7% | ||
| Q2 25 | 17.3% | -0.8% | ||
| Q1 25 | 23.9% | -0.6% | ||
| Q4 24 | 16.7% | -3.9% | ||
| Q3 24 | 31.8% | -1.9% | ||
| Q2 24 | 18.9% | -10.2% | ||
| Q1 24 | 11.8% | 0.2% |
每股收益（稀释后）PRPRGO
| Q4 25 | $0.48 | $-10.23 | ||
| Q3 25 | $0.08 | $0.05 | ||
| Q2 25 | $0.28 | $-0.06 | ||
| Q1 25 | $0.44 | $-0.05 | ||
| Q4 24 | $0.31 | $-0.32 | ||
| Q3 24 | $0.53 | $-0.15 | ||
| Q2 24 | $0.36 | $-0.79 | ||
| Q1 24 | $0.25 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $153.7M | — |
| 总债务越低越好 | $3.5B | — |
| 股东权益账面价值 | $10.3B | $2.9B |
| 总资产 | $17.9B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资PRPRGO
| Q4 25 | $153.7M | — | ||
| Q3 25 | $111.8M | $432.1M | ||
| Q2 25 | $451.0M | $454.2M | ||
| Q1 25 | $702.2M | $409.9M | ||
| Q4 24 | $479.3M | $558.8M | ||
| Q3 24 | $272.0M | $1.5B | ||
| Q2 24 | $47.8M | $542.8M | ||
| Q1 24 | $12.7M | $658.5M |
总债务PRPRGO
| Q4 25 | $3.5B | — | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.0B | — | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $3.9B | — | ||
| Q1 24 | $3.9B | — |
股东权益PRPRGO
| Q4 25 | $10.3B | $2.9B | ||
| Q3 25 | $10.0B | $4.4B | ||
| Q2 25 | $9.5B | $4.5B | ||
| Q1 25 | $9.4B | $4.4B | ||
| Q4 24 | $9.1B | $4.3B | ||
| Q3 24 | $9.0B | $4.6B | ||
| Q2 24 | $8.3B | $4.5B | ||
| Q1 24 | $7.0B | $4.7B |
总资产PRPRGO
| Q4 25 | $17.9B | $8.5B | ||
| Q3 25 | $17.3B | $10.1B | ||
| Q2 25 | $17.5B | $10.1B | ||
| Q1 25 | $17.1B | $9.8B | ||
| Q4 24 | $16.9B | $9.6B | ||
| Q3 24 | $16.6B | $11.2B | ||
| Q2 24 | $15.4B | $10.4B | ||
| Q1 24 | $15.1B | $10.6B |
负债/权益比PRPRGO
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.43× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $904.3M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | — | $148.6M |
| 自由现金流率自由现金流/营收 | — | 13.4% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | 2.66× | — |
| 过去12个月自由现金流最近4个季度 | — | $145.1M |
8季度趋势，按日历期对齐
经营现金流PRPRGO
| Q4 25 | $904.3M | $175.4M | ||
| Q3 25 | $766.5M | $51.7M | ||
| Q2 25 | $1.0B | $75.9M | ||
| Q1 25 | $898.0M | $-64.5M | ||
| Q4 24 | $871.6M | $312.6M | ||
| Q3 24 | $954.4M | $42.2M | ||
| Q2 24 | $938.4M | $9.5M | ||
| Q1 24 | $647.6M | $-1.4M |
自由现金流PRPRGO
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
自由现金流率PRPRGO
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
资本支出强度PRPRGO
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
现金转化率PRPRGO
| Q4 25 | 2.66× | — | ||
| Q3 25 | 12.94× | 6.89× | ||
| Q2 25 | 5.01× | — | ||
| Q1 25 | 2.73× | — | ||
| Q4 24 | 4.02× | — | ||
| Q3 24 | 2.47× | — | ||
| Q2 24 | 3.99× | — | ||
| Q1 24 | 4.42× | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PR
| Crude Oil | $1.0B | 87% |
| Natural Gas Liquids Reserves | $145.1M | 12% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
